fenfluramine/phentermine (fen-phen)

From Aaushi
Jump to navigation Jump to search
[1][2][3]

Introduction

fenfluramine/phentermine

Taken off the market (1999) because of markedly increased risk of valvular heart disease & myocardial infarction.

Reference[2] &[3] suggest that the risk of valvular heart disease may have been initially overestimated.

More general terms

Components

References

  1. ↑ The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996
  2. ↑ Jump up to: 2.0 2.1 Journal Watch vol 19 #22, pg 177, Nov 15, 1999
  3. ↑ Jump up to: 3.0 3.1 Burger et al J Am Coll Cardiol 34:1153, 1999
Retrieved from "https://aaushi.info/w/index.php?title=A355210&oldid=922857"